T-0 h (baseline, preinfusion) | T-6 h | T-12 h (final infusion) | T-18 h (6 h postinfusion) | |
---|---|---|---|---|
HR | ||||
A: n-3 | 91 ± 19 | 101 ± 20 | 100 ± 21 | 91 ± 25 |
B: LCT | 95 ± 13 | 93 ± 12 | 95 ± 12 | 84 ± 16 |
CO | ||||
A: n-3 | 7.8 ± 2.8 | 8.4 ± 2.7 | 8.5 ± 2.7 | 7.8 ± 3 |
B: LCT | 6.9 ± 1.3 | 7.3 ± 1.9 | 6.8 ± 1.6 | 6.1 ± 1.3 |
SAP | ||||
A: n-3 | 127 ± 19 | 113 ± 14 | 117 ± 15 | 131 ± 24 |
B: LCT | 126 ± 9 | 126 ± 10 | 124 ± 14 | 121 ± 14 |
MPAP | ||||
A: n-3 | 26 ± 5 | 29 ± 4 | 28 ± 7 | 28 ± 6 |
B: LCT | 30 ± 7 | 31 ± 7 | 31 ± 6 | 28 ± 7 |
PW | ||||
A: n-3 | 13 ± 4* | 13 ± 2 | 14 ± 3 | 14 ± 4 |
B: LCT | 16 ± 2 | 17 ± 2 | 17 ± 2 | 16 ± 2 |
PVR | ||||
A: n-3 | 162 ± 122 | 187 ± 98 | 155 ± 68 | 162 ± 92 |
B: LCT | 147 ± 84 | 142 ± 102 | 138 ± 79 | 134 ± 77 |
SVR | ||||
A: n-3 | 822 ± 328 | 644 ± 194 | 629 ± 228 | 864 ± 376 |
B: LCT | 863 ± 217 | 840 ± 274 | 884 ± 298 | 932 ± 238 |
DO 2 | ||||
A: n-3 | 1074 ± 340 | 1171 ± 406 | 1174 ± 372 | 1066 ± 518 |
B: LCT | 966 ± 224 | 1023 ± 330 | 936 ± 227 | 856 ± 225 |
VO 2 /DO 2 | ||||
A: n-3 | 0.22 ± 0.04 | 0.24 ± 0.05 | 0.23 ± 0.04 | 0.25 ± 0.06 |
B: LCT | 0.26 ± 0.05 | 0.25 ± 0.04 | 0.27 ± 0.03 | 0.25 ± 0.04 |
Q s /Q t | ||||
A: n-3 | 33 ± 10 | 31 ± 8 | 33 ± 11 | 28 ± 7 |
B: LCT | 28 ± 11 | 27 ± 6 | 25 ± 8 | 25 ± 9 |
BT | ||||
A: n-3 | 38.1 ± 1 | 38 ± 0.9 | 38.1 ± 0.8 | 37.6 ± 1.2 |
B: LCT | 37.6 ± 0.4 | 37.5 ± 0.6 | 37.6 ± 0.4 | 37.1 ± 1 |